A 5-Feature Radiomics Model to Predict Refractory Disease in Early-Stage Hodgkin Lymphoma

A study of the use of precision-medicine based "radiomic" features to evaluate risk of refractory disease in early-stage Hodgkin lymphoma showed promising results.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2UVWlE7